IGC Pharma (IGC) Return on Equity [ROE] (2011 - 2026)
IGC Pharma's Return on Equity [ROE] came in at -38.58% for FY2026, up 65.75 percentage points from -104.33% in FY2025.
Powered by 
Analysis
IGC Pharma (IGC) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
Going back to FY2012, IGC Pharma's Return on Equity [ROE] data covers 15 years.
- Return on Equity [ROE] carries a five-year change of -8.89 percentage points (FY2021 to FY2026).
- The FY2026 figure represents the highest annual Return on Equity [ROE] since FY2021.
- Per Business Quant, earlier years put Return on Equity [ROE] at -104.33% in FY2025 (+12.62 pp), -116.95% in FY2024 (-57.64 pp), -59.30% in FY2023 (-6.33 pp) and -52.97% in FY2022 (-23.27 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 | -103.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -103.66% |
| Sep 30, 2025 | -91.00% |
| Jun 30, 2025 | -102.24% |
| Mar 31, 2025 | -113.15% |
| Dec 31, 2024 | -129.20% |
| Sep 30, 2024 | -164.76% |
| Jun 30, 2024 | -175.03% |
| Mar 31, 2024 | -158.79% |
| Dec 31, 2023 | -122.20% |
| Sep 30, 2023 | -79.16% |
| Jun 30, 2023 | -76.80% |
| Mar 31, 2023 | -69.25% |
| Dec 31, 2022 | -72.69% |
| Sep 30, 2022 | -66.90% |
| Jun 30, 2022 | -69.72% |
| Mar 31, 2022 | -56.27% |
| Dec 31, 2021 | -37.75% |
| Sep 30, 2021 | -36.21% |
| Jun 30, 2021 | -27.01% |
| Mar 31, 2021 | -32.47% |
API Access
IGC Pharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();